Ebsiron is a multi-strategy hedge fund built on a disciplined, data-driven approach to short-term trades. Our mission is simple yet ambitious: to deliver consistent, risk-aware returns by uncovering niche market opportunities through advanced analytics and proprietary models.
Launched in November 2025, Ebsiron specializes in long/short equity strategies and is open to both U.S. and international investors. We serve Qualified Clients, family offices, retirement plans, and financial advisors seeking measured capital growth with embedded risk controls.
Our Origins & Philosophy
Ebsiron is more than a trading strategy; it represents the culmination of over a decade of research, refinement, and resilience. We have pursued the belief that financial data reveals statistical patterns that can be harnessed for superior investment outcomes.
Our proprietary algorithms, tested across multiple market regimes, were designed to meet the needs of professionals who value disciplined, periodic decision making rather than constant screen-watching.
Guiding Principles
Our philosophy is anchored in pragmatic, disciplined trading using following principles:
Avoid chasing home runs - focus on steady gains.
No attachment to any single ticker - diversification is key.
Wholesale trader mindset - operate with scale and discipline.
Target high beta, high volume leveraged ETFs for efficiency.
No day trading - patience drives performance.
Why Ebsiron is Different
Our competitive edge lies in three pillars:
Manager Alignment & Conviction – Strategies validated with personal capital.
Rigorous Analytical Foundation – Over 10 years of proprietary research and refinement.
Systematic, Data-Driven Approach – Models built on the statistical properties of financial instruments.
Value Proposition
For investors, our approach translates into tangible advantages:
Liquidity – All trades executed via ETFs for transparency and intraday access.
Flexibility – Ability to profit in both rising and falling markets through long and inverse ETFs.
Diversification – Sector rotation across Technology, Financials, Biotech etc.
Risk Management – Avoidance of single-stock risk through diversified exposures.
Disclaimer
This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any such offer or solicitation will be made solely by the Fund’s Confidential Private Placement Memorandum (“PPM”) and only to persons who meet the Fund’s investor qualification standards, including being an Accredited Investor as defined in Rule 501 of Regulation D under the Securities Act of 1933, and a Qualified Purchaser or Qualified Client, as applicable, under relevant federal and state securities laws.
Past performance is not indicative of future results. The investment strategies described herein involve significant risks, including the risk of loosing your entire investment, and there is no guarantee that investment objectives will be achieved. Investors should have the financial ability and willingness to accept the risk of loosing entire investment, and are encouraged to consult their own independent legal, tax, and financial advisors before investing.
Certain information contained herein may be based on or derived from independent third-party sources that Ebsiron Fund LP, Ebsiron Capital LLC (“Ebsiron”) believes to be reliable; however, Ebsiron has not independently verified such information and makes no representations or warranties as to its accuracy or completeness. All statements other than statements of historical fact, including statements about future performance, are forward-looking statements and are based on current expectations, beliefs, and assumptions. Actual results may differ materially from those expressed or implied. No person may rely on the information contained in this presentation as investment advice.